Squarepoint Ops LLC Acadia Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 572,890 shares of ACAD stock, worth $9.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

572,890

Previous 848,441 32.48%

Holding current value

$9.84 Million

Previous $13.8 Million 36.06%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $4.17 Million - $5.27 Million	-275,551 Reduced 32.48%	572,890 $8.82 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $2.35 Million - $2.96 Million	-160,542 Reduced 15.91%	848,441 $13.8 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $13 Million - $22.6 Million	731,931 Added 264.19%	1,008,983 $18.7 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $5.76 Million - $8.8 Million	277,052 New	277,052 $8.67 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $3.57 Million - $4.57 Million	218,530 New	218,530 $4.11 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $264,999 - $343,128	-18,781 Reduced 3.8%	475,921 $7.79 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $3.84 Million - $8.03 Million	295,079 Added 147.82%	494,702 $6.97 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $3.54 Million - $4.65 Million	169,132 Added 554.69%	199,623 $4.84 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $1.43 Million - $2.3 Million	-85,059 Reduced 73.61%	30,491 $712,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $1.82 Million - $2.86 Million	115,550 New	115,550 $1.92 Million
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $816,052 - $1.79 Million	-32,616 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $7.27 Million - $10.1 Million	-177,057 Reduced 84.44%	32,616 $1.74 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $5.23 Million - $8.18 Million	143,534 Added 217.02%	209,673 $8.65 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $518,114 - $695,877	-13,197 Reduced 16.63%	66,139 $3.21 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $4.83 Million - $7.15 Million	-152,621 Reduced 65.8%	79,336 $3.35 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $5.61 Million - $7.97 Million	155,002 Added 201.42%	231,957 $9.92 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $1.71 Million - $3.39 Million	76,955 New	76,955 $2.77 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $445,337 - $754,072	-27,541 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $326,825 - $523,103	-22,823 Reduced 45.32%	27,541 $445,000
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $656,242 - $1.1 Million	50,364 New	50,364 $1.05 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $1.02 Million - $1.52 Million	-67,965 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $171,850 - $247,259	-7,648 Reduced 10.11%	67,965 $1.53 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $1.14 Million - $1.66 Million	42,357 Added 127.37%	75,613 $2.28 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $980,719 - $1.28 Million	33,256	33,256 $1.25 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Acadia Pharmaceuticals Inc Transaction History